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Abstract
Background: To examine the level and patterns of self-reported medication use (prescription and
non-prescription drugs) among 70–74 year old individuals living in the community, and to explore
self-reported indications for use, and factors possibly predictive of drug use.
Methods: A health survey carried out in 1997–99 in the county of Hordaland (Western Norway)
in the setting of a population study. A self-administered questionnaire was mailed to 4338 persons
born in 1925–27, and a health check-up was offered. Drug use the previous day was reported (point
prevalence). 3341 (77.0%) persons who responded, comprise the material for the analyses.
Results: Between one third (males) and one quarter (females) did not take any drug the previous
day. Mean number of drugs among users was 2.8 (men and women). 32% used three or more drugs
and 11.5% five or more. Hypertension and other cardiovascular problems were by far the most
common reasons for drug use, fol l o w e d  b y  r e s p i r a t o r y ,  m u s c uloskeletal and mental health
problems. Self-reported poor health, a high Body Mass Index (BMI), and being an ex-smoker (but
not currently a smoker) correlated with increasing number of drugs taken.
Conclusion: Among 70–74-year old individuals living in the community no use of medication was
more common than major polypharmacy (5+ drugs). Persons who had fallen ill and were put on
regular medication, probably tended to quit smoking, while those who remained healthy, continued
to smoke.
Background
Elderly people are the major drug users in the community
[1]. In old age, complex medical conditions are relatively
frequent, which may indicate multiple drug therapy. In
Sweden, drug use among elderly probands has been sur-
veyed over many years [2]. In Norway remarkably little is
known about who use drugs, and for which reasons,
although whole sales statistics are available [3]. Previous
Norwegian studies have been carried out on general prac-
titioners' prescription habits [4], on drug use in nursing
homes [5,6], or on the use of particular drugs, e.g. antihy-
pertensives, psychotropics and diuretics [7].
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Although appropriate drug therapy can alleviate symp-
toms and reduce both morbidity and mortality, the use of
numerous drugs also implies increased risks of side-
effects, drug-drug and drug-disease interactions, inappro-
priate use, and non-compliance. Physiological changes,
such as decreased renal function and mental impairment,
make the elderly more vulnerable to drug related harm
[8]. Principally there are three major categories of sub-
optimal drug use: over-use or polypharmacy, inappropri-
ate use, and under-use [9,10]. Under-utilization may
imply under-prescribing of potentially beneficial thera-
pies because of high age [10]. Polypharmacy can be
defined either as the concomitant use of multiple drugs,
or the use of more medications than are clinically indi-
cated [11]. In epidemiological studies, polypharmacy can
only be assessed according to the first definition, by a cut-
off value based on a simple count of medications.
Although no specific number of drugs can be established
to define polypharmacy, cut-off-points from three to five
daily drugs per patient have been commonly used [11,9].
In the present study we explore the level and patterns of
medication use (prescribed and over the counter – OTC –
drugs) among 70–74 year old individuals living in the
community, in relation to self-reported reasons for use,
sociodemographic factors, and various health status and
lifestyle parameters.
Methods
In 1997–1999 a population based health survey was car-
ried out in Hordaland County in western Norway (with
capital city Bergen) [12]. In total, 44 342 persons were
invited, among whom 4338 were born between 1925 and
1927 and were living in Bergen and three nearby commu-
nities. The survey was carried out by the National Health
Screening Service, Oslo (now The Norwegian Institute of
Public Health) in cooperation with the University of Ber-
gen.
The study was approved by the Regional Committee for
Medical Research Ethics and the Norwegian data Inspec-
torate.
A questionnaire was mailed to the invited persons, along
with an invitation to a health check-up. The filled-in ques-
tionnaires were collected at the screening station, where
measurements of blood pressure, height and weight, as
well as blood-tests were performed. A written consent was
given at the screening station.
The questionnaire included the following questions
regarding drug consumption: Did you take any drug yes-
terday? (yes/no). If yes: report the name of the drug, the
reason for taking it, and whether you usually take this
drug every day (yes/no). The questionnaire provided
space for reporting up to nine different drugs, and partic-
ipants were asked to continue on a separate sheet if
needed. It was specified that "drugs" meant all kinds of
medicines: with and without prescription, herbal drugs,
vitamins and minerals. Tablets, inhalators, injections,
suppositories, ointments as well as droplets were
included.
The drug names written by respondents were subse-
quently coded according to the Anatomical Therapeutic
Chemical (ATC) classification system [13] and were clas-
sified to the substance (5th) level of the ATC codes. The
reported reasons for drug use were coded according to the
International Classification for Primary Care (ICPC) [14].
The questionnaire also addressed physical exercise, smok-
ing and alcohol use, general health and depressive symp-
toms Table (1), as well as duration of formal education.
For analysis purpose, the answers on questions on past
and present smoking and alcohol use were converted to
categories.
In the present paper we focus on drugs with an ATC-code.
The use of non ATC-drugs will be reported elsewhere.
Data from the 3341 individuals aged 70–74 who
responded to the invitation (response rate 77.0%) com-
prise the material for this article.
Statistical analyses were performed using SPSS version 11.
Bivariate comparisons were examined by chi-square test
(categorical variables) and independent samples t-test
(continuous variables). Bivariate relationships were com-
puted by means of Pearson's correlation coefficient (con-
tinuous variables). Binary logistic regression analyses
(enter) were carried out to examine the relationships
between drug use and health status and lifestyle measures.
Results
Out of the 3341 respondents, 948 (28.4%) reported they
did not use any drugs the previous day (men: 33.1%,
women: 24.6%). 2393 had taken at least one drug, in total
6 590 drugs (2719 drugs used by 985 men, 3871 drugs
used by 1408 women). This corresponds to an average use
of 1.97 drugs per person (men: 1.85, women: 2.07, p <
0.01) or 2.75 drugs per individual on treatment (both
genders).
The maximum number of different drugs taken by one
person on the previous day was 17. Among women,
33.0% used three or more drugs, 19.4% four or more, and
11.7% five or more drugs (Figure 1). Corresponding fig-
ures for men were 30.1, 17.6 and 11.4%, respectively. The
majority reported they used the medications every day, as
84% of the 6590 drugs were taken on a daily basis.BMC Public Health 2006, 6:121 http://www.biomedcentral.com/1471-2458/6/121
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The "top five" drug groups comprised close to one third of
all medication used. These drugs were from the top: low
dose aspirin (used by 15.5% of respondents), beta-block-
ers (15.5%), statins (13.0%), calcium channel blockers
(11.7%), and ACE-antagonists (9.1%).
Reasons for use were given for 4 970 (75.4%) of the 6 590
drugs. The "top five" diagnostic reasons were: Elevated
blood pressure (men: 409, women: 566, corresponding to
27.8 and 30.3% of respondents, respectively), cardiovas-
cular problems other than hypertension [men: 514
(34.9%), women: 365, (19.5%)], respiratory tract prob-
lems, incl. allergy [men: 261(17.7%), women: 298
(16.0%)], musculo-skeletal problems [men: 68 (4.6%),
women: 322 (17.2%)], and mental health problems
[men: 75 (5.1%), women: 200 (10.7%)]. Table 3 shows
the most frequently used drugs for the most common
diagnostic categories.
Potentially influencing factors
In bivariate analyses, female sex, low education, a poor
self-reported health and feeling depressed correlated pos-
itively with increase drug use Table (4). Table 5 shows the
association between lifestyle factors and drug use: Non-
smokers used more drugs compared to daily cigarette
smokers. However, those who had quit smoking used
generally more drugs compared to all others. Abstinence
from alcohol and performing no physical exercise corre-
lated with increasing drug use, as was being overweight or
obese.
An increasing use of drugs correlated positively with
number of daily cigarettes smoked (Pearson's correlation
coefficient: 0.058 p = 0.01), with the use of non ATC-
drugs like herbal drugs, fish oil etc (Pearson's correlation
coefficient: 0.074, p < 0.01), and with decreasing systolic
The Hordaland Health Study (HUSK), 70–74 year old individ- uals Figure 1
The Hordaland Health Study (HUSK), 70–74 year old individ-
uals. Number of different ATC-drugs taken – one day preva-
lence
Table 1: Questions on lifestyle and health status
Physical activity
Which level of physical activity have you had during the last year?
• Easy exercise:none, less than 1 hour/week, 1–2 hours/week, 3 hours or more/week
• Hard exercise:none, less than 1 hour/week, 1–2 hours/week, 3 hours or more/week
Use of alcohol
• Are you totally abstinent from alcohol? Yes/no
• How many times a month do you usually drink alcohol? Number of times:
• How many glasses of beer, wine or spirits do you usually drink during a two-week period? Number of glasses:
Smoking
• Do you smoke cigarettes daily? Yes/no
• If you used to be a daily smoker, since when did you quit? Number of years:
• If you are or were a daily smoker, how many cigarettes do or did you usually smoke during a day? Number of cigarettes:
• For how many years have you been a daily smoker? Number of years:
General health
• How is your present general state of health? Bad/not quite good/good/very good
Depressed mood
• Have you felt down/depressed during the last two weeks? Yes/a little/considerably/very muchBMC Public Health 2006, 6:121 http://www.biomedcentral.com/1471-2458/6/121
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blood pressure (Pearson's correlation coefficient: -0.041,
p = 0.02), and diastolic blood pressure (Pearson's correla-
tion coefficient: -0.090, p < 0.01) at the health check-up.
In binary logistic regression analyses, female sex (OR 1.6
{95% CI 1.04–2.5}), a self-reported poor health (OR 3.0
{1.8–5.0}), and a BMI < 27 kg/m2 (OR 1.9 {1.2–3.0})
correlated positively with medication use (data not shown
in tables).
Discussion
The validity of elderly persons' self-reported drug use and
reasons for use may be questioned. However, asking
which drugs were taken the previous day (point prevalence)
probably minimized recall bias [15]. Asking which drugs
were actually taken also bypassed the problem of non-
compliance, as we know that around 25% of prescribed
drugs may not be used [16]. Data quality in our study was
considered good, as drug names were generally correctly
written and only few questionnaires had to be rejected
because of inconsistencies. The high response rate (77%)
also contributes to strengthen the validity of the results.
We may assume, however, that the 23% who did not par-
ticipate, would have been found to use more drugs than
the respondents, as people with poor health, poor social
status and unhealthy lifestyle are known to be generally
Table 2: The Hordaland Health Study (HUSK) 1997–99, 70–74 year old individuals Number of persons invited and examined1
Year of birth Number invited Number examined Attendance2
All Men Women Men (%) Women (%) Bergen (%) Rural areas (%)
1925 1 401 604 797 466 (77.2) 581 (72.9) 901 (72.6) 146 (78.1)
1926 1 451 618 833 481 (77.8) 629 (75.5) 931 (75.3) 179 (83.3)
1927 1 486 646 840 526 (81.4) 658 (78.3) 1 010 (78.8) 174 (84.9)
Total 4 338 1 868 2 470 1 473 (78.9) 1 868 (75.6) 2 842 (76.2) 499 (82.2)
1All, men and women: 4 338 invited, 3 341 (77%) examined
2 Both genders
Table 3: The Hordaland Health Study (HUSK) 1997–99, 70–74 year old individualsThe most frequently used drugs (ATC- code/
therapeutic group) for the five most frequent indications. N = 3 341
Hypertension n = 975 Cardiovascular problems n 
= 8791
Respiratory problems n= 
5592
Musculoskeletal problems 
n = 3903
Mental problems n = 2754
C03 Diuretics: 107 B01 AA03 Warfarin: 52 R01 Nasal preparations: 52 A12AA Calcium: 63 N05A Antipsychotics: 28
C07 Beta blocking agents: 
226
B01 AC06 Low dose 
acetyl-salicylic acid: 313
R03 Drugs for obstructive 
airway diseases: 387
H02 Corticosteroids: 31 N05BA Anxiolytics: 47
C08 Calcium channel 
blockers: 224
C01 A Cardiac glycosides: 
28
R06 Antihistamines: 54 M01A Antiinflammatory 
agents: 108
N05C Hypnotics: 83
C09 A+B ACE-inhibitors: 
200
C01 DA Nitrates: 88 M05B Drugs affecting bone 
mineralization: 46
N06A Antidepressants: 94
C09 C Angiotensin II 
antagonists: 87
C03 Diuretics: 30
C07 Beta blocking agents: 
147
C08 Calcium channel 
blockers: 76
C09 A+B ACE inhibitors: 
29
C10 Lipid reducing agents: 
36
Sum: 844 (87% of total) Sum: 799 (91% of total) Sum: 493 (88% of total) Sum: 248 (64% of total) Total: 252 (95% of total)
1angina pectoris: 159, myocardial infarction: 85, atrial fibrillation: 41 (32% of n)
2asthma: 358, allergy: 76 (78% of n)
3osteoporosis: 132, rheumatoid arthritis: 90, back pain: 25 (63% of n)
4sleep disturbancies: 128, depression: 57, anxiety: 56 (88% of n)BMC Public Health 2006, 6:121 http://www.biomedcentral.com/1471-2458/6/121
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over-represented among non-respondents in health sur-
veys [17].
75% of those who had taken any drug gave an explicit rea-
son for using it. Probably, the remaining quarter did not
know or was not sure about the indications (low dose
ASA, beta-blockers and estrogens were the main drug
groups taken by those who gave no reason for taking
them). Our figures, however, correspond well with the
results in a comprehensive British interview study among
people aged 65 +, where 76% knew the reason for taking
their medications [16].
In our study, 28% (men: 33%, women: 25%) reported no
use of ATC-drugs on the day previous to the survey. Direct
comparison with other studies is complicated by differ-
ences in data collection, population sample and kind of
drugs included. The previously cited British interview
study, gave results almost identical with ours, as roughly
one third had taken no drugs during the last 24 hours, and
mean number of drugs for those on treatment was 2.8
[16]. In a Swedish study among 70-year old individuals
performed in 2000, only one in five men and one in ten
women reported to use no drugs at all [2]. Average
number of drugs among those on treatment in Sweden
was 3.3 in men and 4.0 in women, which is substantially
higher than our figures. This is, however, not surprising, as
the overall drug consumption in Norway (measured in
daily doses per inhabitants) only reached 60% of the
Swedish level in 2000 [3]. A corresponding study carried
out by the Swedish authors back in 1972, showed that
40% of men and 24% of women did not use any drug. The
proportion who took four or more drugs increased from
21% (1972) to 28% (2000) in men and from 30% to 41%
in women [2].
A Danish study among 75-year old persons living in the
community revealed that only 3% of the subjects did not
take any drug, and that the average total number of drugs
– prescribed and OTC – was as high as 5.4 [18]. The higher
level was probably partly caused by examination of drug
storages in patients' homes and thereby including drugs
that were in fact not used, as total drug consumption in
Denmark is slightly lower compared to Norway (close to
90%) [3]. In the Danish study, CNS drugs were the most
commonly used category, compared to cardiovascular
drugs in our and other studies [1,2,16,19]. 26% of the eld-
erly Danes had taken a benzodiazepine the previous day,
reflecting the relatively high use of benzodiazepines in
Denmark in the late 1990s [20]. In our study, only 5%
reported having taken a benzodiazepine, corresponding
to the average level of use in the population in Hordaland
County [3]. Other studies have shown that use of benzo-
diazepines increases by age [21], and we can only specu-
Table 4: The Hordaland Health Study (HUSK) 1997–99, 70–74 year old individualsDrug use related to sociodemographic factors and 
health status. Bivariate analyses1,2
Explanatory variables Use of any drug % 1 Number of drugs used2 Use of five or more drugs 
% 1
Categories
Sex Males 65.5 1.85 10.1
females 74.4 2.07 10.7
(p < 0.01) (p < 0.01) (p = 0.5)
Dwelling urban 70.6 1.98 10.3
rural 70.3 1.94 10.4
(p = 0.9) (p = 0.7) (p = 0.9)
Education high 68.3 1.92 9.6
low 72.1 2.00 10.6
(p = 0.1) (p = 0.4) (p = 0.5)
Self-reported health good 62.2 1.49 4.8
poor 86.3 2.93 21.4
(p < 0.01) (p < 0.01) (p < 0.01)
Feeling depressed yes 86.3 3.18 23.9
no 69.2 1.88 9.3
(p < 0.01) (p < 0.01) (p < 0.01)
1chi squared test
2independent samples t-testBMC Public Health 2006, 6:121 http://www.biomedcentral.com/1471-2458/6/121
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late if our results are influenced by selection bias or
possible underreporting.
The lower use of drugs in our study compared to neigh-
bouring countries probably reflects habits and preferences
in the population as well as among physicians. In a pop-
Table 5: The Hordaland Health Study (HUSK) 1997–99, 70–74 year old individuals Drug use related to lifestyle factors. Bivariate 
analyses1,2
Explanatory variables Use of any drug (%) 1 Number of drugs used2 Use of five or more drugs 
(%) 1
Categories
Daily cigarette smoking yes (n = 482) 65.1 1.71 10.8
71.4 2.02 9.1
no (p = 0.01) (p < 0.01) (p = 0.3)
Ever smoked yes 70.7 2.02 11.7
70.3 1.91 8.6
no (n = 1421) (p = 0.8) (p = 0.1) (p < 0.01)
Quit smoking yes (n = 1347) 74.0 2.18 12.8
68.2 1.83 8.7
all others (p < 0.01) (p < 0.01) (p < 0.01)
Number of cigarettes now 1–10 (n = 379) 66.5 1.72 9.5
11+ (n = 129) 62.6 1.79 9.3
(p = 0.2) (p = 0.8) (p = 0.7)
Smoked >10 cig daily for = 
> 30 years
yes (n = 357) 69.8 2.29 14.8
all others 70.6 1.93 9.8
(p = 0.8) (p < 0.01) (p < 0.01)
>10 cig daily for = > 30 
years & smoking now
yes(n = 114) 60.6 1.75 8.8
all others 70.9 1.98 10.4
(p = 0.02) (p = 0.2) (p = 0.8)
>10 cig daily for = > 30 
years & quit smoking
yes (n = 237) 73.5 2.56 18.1
all others 70.3 1.93 9.8
(p = 0.4) (p < 0.01) (p < 0.01)
Use of alcohol yes 69.2 2.08 10.3
no (n = 823) 73.6 1.93 10.9
(p = 0.02) (p = 0.1) (p = 0.6)
Use of alcohol > 10 times/
month
yes (n = 185) 69.4 1.96 10.8
no 71.3 1.99 10.8
(p = 0.7) (p = 0.8) (p = 1.0)
Use of > 10 glasses of 
alcohol/2 weeks
yes (n = 266) 67.6 1.89 10.5
No 70.7 2.01 10.9
(p = 0.3) (p = 0.2) (p = 0.9)
Light exercise yes (n = 2 598) 69.2 1.87 9.0
no 77.9 2.62 18.7
(p < 0.01) (p < 0.01) (p < 0.01)
Intensive exercise yes (n = 722) 64.3 1.65 6.6
No 72.8 2.12 11.9
(p < 0.01) (p < 0.01) (p < 0.01)
Body mass index > 27 yes (n = 1244) 76.7 2.25 12.8
No 66.9 1.81 8.9
(p < 0.01) (p < 0.01) (p < 0.01)
Body mass index > 30 yes (n = 462) 79.5 2.51 16.5
No 69.1 1.88 9.3
(p < 0.01) (p < 0.01) (p < 0.01)
1chi squared test
2independent samples t-testBMC Public Health 2006, 6:121 http://www.biomedcentral.com/1471-2458/6/121
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ulation traditionally founded on fishing and agriculture
like on the Western coast of Norway, it is often considered
a benefit to be independent of regular medication, and to
cope with occasional illnesses without drugs. Norwegian
family physicians may also be more cautious than col-
leagues elsewhere in prescribing regular medications for
elderly people, especially drugs with potential CNS side-
effects. On the other hand, we may simply lag behind our
neighbours in an ongoing process towards increased drug
use. As the Swedish study shows, drug use among 70 year
old persons increased remarkably during three decades,
despite generally improved health status [2]. However,
over that period, a range of new drugs have been intro-
duced, especially for the treatment of cardiovascular risk
factors [22,23]. Recently, focus has switched from con-
cerns of unnecessary treatment to possible under-prescrib-
ing of potentially beneficial therapies to seniors [10]. Low
dose aspirin, beta-blockers and lipid lowering agents were
already the dominant drug groups in our sample (13%
used a statin). The sales of lipid reducing agents have dou-
bled in Norway from 1999 to 2004 [3], and recently, 13%
of presumed healthy, low-risk 75-year old women in Oslo
were found to use statins [24].
In our study, 31.7% had used at least three drugs, while
11.5% had taken five or more daily drugs. This is less com-
pared to the Swedish [2] and the Danish [18] studies cited
above, but equals the results of the British interview study
[16]. Based on data from a Danish prescription database,
Bjerrum found that on a random day, close to 5% of 70–
74 year old persons used five or more prescribed drugs
[11]. He also found a six-fold variation between general
practices regarding the prevalence of major polypharmacy
(5+ drugs), correlating – among other things – with the
doctors' workload, as increasing workload implied
increased prescription.
Potentially influencing factors
Many of the factors which correlated positively with drug
use in our study Tables (4 and 5) have also been identified
by others: female sex, a relatively low education (espe-
cially for respiratory and cardiovascular drugs) [1]
depressed mood, and a poor self-reported general health
[25]. Not surprisingly, we found (in bivariate analyses)
that reporting poor general health, feeling depressed, and
performing no regular exercise were all strongly correlated
with drug use, both with the use of any drug, with an
increasing number of drugs used, as well as with the con-
comitant use of five or more different drugs.
It may be surprising that being a non-smoker and being
abstinent from alcohol both correlated with increased use
of drugs. However, having quit smoking strongly corre-
lated to increased drug use. In the group who had smoked
more than 10 cigarettes a day for 30 years or more, and
who now had quit smoking, (n = 237), one out of six used
five or more drugs. That former smokers were most likely
to be on medication, corresponds to what has been found
in other studies [25,26]. But how can we explain that
heavy present smokers (more than 10 cigarettes a day for
30 years or more, n = 114) in fact used less drugs than the
average? One explanation may be that people who had
fallen ill and were put on regular medication, quitted
smoking, while those who remained healthy in spite of
their smoking habit, were more likely to continue smok-
ing. Another probable explanation may be that a substan-
tial proportion of heavy smokers died before reaching the
age of 70–74 years [27].
A corresponding relationship may also be valid for alco-
hol use, but because we did not ask about quitting drink-
ing, we could not explore this. The negative correlation
between use of alcohol and medications was nevertheless
weaker than for smoking. Even regular drinkers (> 10
drinking days a month or > 20 glasses of alcohol a month)
used (non-significantly) less drugs compared to the rest of
the sample. This corresponds with epidemiological data
supporting that regular moderate alcohol consumption is
associated with less morbidity and mortality [28]. An
American study found no significant relationship between
current alcohol use and current medication use among
persons 65 and over [25]. However, in our study under-
reporting of actual drinking and a selection effect imply-
ing that heavy smokers and drinkers with poor health may
be overrepresented among the non-responders can not be
ruled out.
Conclusion
No use of medication was more common than major
polypharmacy (5+ drugs). Among 70–74 year old individ-
uals living in the community, between one third (males)
and one fourth (females) did not use prescription or OTC
drugs. Mean number of drugs among those on treatment
was 2.8, and 11.5% had taken five or more drugs. Drugs
for hypertension and other cardiovascular risk-factors
were the most frequently used. In bivariate analyses being
an ex-smoker (but not currently a smoker) correlated with
drug use. Female sex (OR 1.6), being overweight (OR 1.9),
and reporting a poor general health (OR 3.0), were factors
that independently predicted medication use in this eld-
erly population.
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